A detailed history of Center Book Partners LP transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Center Book Partners LP holds 23,768 shares of REGN stock, worth $17 Million. This represents 1.62% of its overall portfolio holdings.

Number of Shares
23,768
Previous 4,718 403.77%
Holding current value
$17 Million
Previous $4.96 Million 403.93%
% of portfolio
1.62%
Previous 0.33%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1024.09 - $1201.76 $19.5 Million - $22.9 Million
19,050 Added 403.77%
23,768 $25 Million
Q2 2024

Aug 12, 2024

BUY
$883.2 - $1071.19 $4.17 Million - $5.05 Million
4,718 New
4,718 $4.96 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Center Book Partners LP Portfolio

Follow Center Book Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Center Book Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Center Book Partners LP with notifications on news.